Skip to main content

. 1991 Aug;54(8):746. doi: 10.1136/jnnp.54.8.746

Penicillamine treatment of Wilson's disease and optic neuropathy.

A H Lee, N F Lawton

PMCID: PMC1014489 PMID: 1940953

746

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Chu N. S. Sensory evoked potentials in Wilson's disease. Brain. 1986 Jun;109(Pt 3):491–507. doi: 10.1093/brain/109.3.491. [DOI] [PubMed] [Google Scholar]
Klingele T. G., Burde R. M. Optic neuropathy associated with penicillamine therapy in a patient with rheumatoid arthritis. J Clin Neuroophthalmol. 1984 Jun;4(2):75–78. doi: 10.3109/01658108409053863. [DOI] [PubMed] [Google Scholar]
Pall H. S., Williams A. C., Blake D. R. Deterioration of Wilson's disease following the start of penicillamine therapy. Arch Neurol. 1989 Apr;46(4):359–361. doi: 10.1001/archneur.1989.00520400013007. [DOI] [PubMed] [Google Scholar]
Starosta-Rubinstein S., Young A. B., Kluin K., Hill G., Aisen A. M., Gabrielsen T., Brewer G. J. Clinical assessment of 31 patients with Wilson's disease. Correlations with structural changes on magnetic resonance imaging. Arch Neurol. 1987 Apr;44(4):365–370. doi: 10.1001/archneur.1987.00520160007005. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES